Editors’ Picks: July Highlights From AACR Journals
Grab a cold drink and escape the midsummer heat with July’s rendition of Editors’ Picks. This month, the editors...
Grab a cold drink and escape the midsummer heat with July’s rendition of Editors’ Picks. This month, the editors...
In the United States, nearly 24,000 people are estimated to receive a brain or nervous system cancer diagnosis in 2020....
The cover of the inaugural issue of Blood Cancer Discovery, launched in July 2020, does not feature stained tissue...
The new year has already ushered in some changes, but one thing stays the same. Each month, we’ll continue to feature the “must read” articles handpicked by the editors...
On May 4, the U.S. Food and Drug Administration (FDA) approved a combination of molecularly targeted therapeutics for the...
As the deep reds and yellows of fall leaves give way to twinkling holiday lights, we welcome the new...
Immunotherapy has revolutionized cancer treatment over the past decade, providing potentially lifesaving therapies to many patients who otherwise would have limited options. Despite its success...
The staff of Cancer Research Catalyst was pleased to introduce a new feature this year: Editors' Picks, a monthly...
As you say farewell to summer, say hello to the latest installment of Editors’ Picks selected by the editors...
Medical risks of obesity include high blood pressure, type 2 diabetes, and cardiovascular diseases. Additionally, obesity has been associated...
2023 is upon us, but before we dive into the new year, let’s look back at the featured articles...
Although checkpoint inhibitors and other immunotherapies are remarkably effective for patients with some cancers, demonstrating durable antitumor activity and/or...
Last week, a flurry of U.S. Food and Drug Administration (FDA) oncology approvals concluded with the approval of the...
As we welcome in August, it’s time to look back at some of the top articles published in the nine AACR journals...
While the incidence of melanoma has been rising, the mortality rate has experienced a steep decline over the past few years. This is largely attributable...
The days are getting longer and warmer, and visions of beach trips, cookouts, and picnics occupy our minds. While this year’s summer will likely look different due to the ongoing COVID-19 pandemic, months...
Several options are available for the treatment of breast cancer, including local therapies such as surgery and radiation therapy,...
In the past year, the number of American teenagers using tobacco products has increased by nearly 40 percent, reversing...
The 2020 Nobel Prize in Chemistry was awarded to Fellows of the AACR Academy Emmanuelle Charpentier, PhD, and Jennifer A. Doudna, PhD, for their groundbreaking development of the CRISPR-Cas9 genome editing system. This technology allows researchers to accurately delete,...
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the lung cancer community during...
Tuesday marked a milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced its first approval...
Cancer of the esophagus, a relatively rare cancer, is a diagnosis that approximately 18,440 Americans are expected to receive...
Monday afternoon, First Lady Jill Biden visited the Medical University of South Carolina (MUSC) Hollings Cancer Center as part...
Guest Post By Fadlo R. Khuri, MD Winship Cancer Institute of Emory University
As lung cancer awareness month drew to a close, the U.S. Food and Drug Administration (FDA) added another therapeutic...
AACR Virtual Annual Meeting II featured more than 20 minisymposia sessions during the three-day conference. One such minisymposium focused on Infection and...
Two studies published today in the AACR's journal Cancer Research describe developing CAR T cells to make them safe...
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
As a scientific organization focused on preventing and curing all cancers, the American Association for Cancer Research (AACR) embraces...
With the August 2020 U.S. Food and Drug Administration approvals of the Guardant 360 CDx and FoundationOne Liquid CDx...